Patent · US Active

Substituted imidazopyrimidines and triazolopyrimidines

US9051323B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Stephan Siegel · Berlin, DE
Andreas Wilmen
Susanne Röhrig · Hilden, DE
Niels Svenstrup · Copenhagen, DK
Mark Jean Gnoth · Mettmann, DE
Stefan Heitmeier · Wülfrath, DE
Ulrich Rester · Wuppertal, DE
Dmitry Zubov · Remscheid, DE
Jochen Strayle · Wuppertal, DE
Michael Sperzel · Wuppertal, DE

Key dates

Filing date	Sep 24, 2012
Grant date	Jun 9, 2015
Priority date	—
Expiry date	Sep 24, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to substituted imidazo- and triazolopyrimidines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of haematological disorders, preferably of leucopenias and neutropenias.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.